(redirected from obstructive pulmonary disease)
Also found in: Dictionary, Thesaurus, Medical.
Related to obstructive pulmonary disease: emphysema, COPD, Obstructive Lung Disease
References in periodicals archive ?
Chronic obstructive pulmonary disease is most prevalent in manual labourers 68% (n: 34), followed by office staff 20% (n: 10), Shop owners 8% (n: 4%) and Homemakers 2% (n: 1).
The drug indicated a statistically-significant improvement in lung function in patients with moderate to very severe stable chronic obstructive pulmonary disease when compared with individual component that included either aclidinium bromide or formoterol.
KEY WORDS: Procalcitonin, C-reactive protein, Acute exacerbations of chronic obstructive pulmonary disease.
This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Because there is considerable evidence that asthma associated with airflow limitation is a strong risk factor for subsequent chronic obstructive pulmonary disease, the prevention of early-life pneumonia and of the factors that determine low lung function in infancy may contribute significantly to decrease the public health burden of chronic obstructive pulmonary disease," wrote Dr.
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease state characterised by chronic airflow limitation which is progressive, not fully reversible and associated with an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking1.
World COPD Day is an annual event organized to improve awareness and care of chronic obstructive pulmonary disease around the world.
According to the firm, the new product, Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg, is a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysemam.
ClickPress, Tue Dec 03 2013] GlobalData's clinical trial report, "Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2013" provides data on the Chronic Obstructive Pulmonary Disease (COPD) clinical trial scenario.
Q My husband has chronic obstructive pulmonary disease, which I understand may increase his risk for stroke.

Full browser ?